Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proassurance (PRA) Cash & Equivalents (2016 - 2025)

Proassurance (PRA) has disclosed Cash & Equivalents for 17 consecutive years, with $54.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents rose 20.22% to $54.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $54.5 million, a 20.22% increase, with the full-year FY2024 number at $54.9 million, down 16.72% from a year prior.
  • Cash & Equivalents was $54.5 million for Q3 2025 at Proassurance, up from $41.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $214.8 million in Q1 2021 to a low of $30.0 million in Q4 2022.
  • A 5-year average of $77.5 million and a median of $54.9 million in 2024 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: plummeted 79.61% in 2022, then skyrocketed 119.96% in 2023.
  • Proassurance's Cash & Equivalents stood at $143.6 million in 2021, then plummeted by 79.14% to $30.0 million in 2022, then surged by 119.96% to $65.9 million in 2023, then fell by 16.72% to $54.9 million in 2024, then decreased by 0.77% to $54.5 million in 2025.
  • Per Business Quant, the three most recent readings for PRA's Cash & Equivalents are $54.5 million (Q3 2025), $41.6 million (Q2 2025), and $43.5 million (Q1 2025).